Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV. Transplant infectious disease : an official journal of the, Transplantation Society, vol.9, pp.165-170, 2007. ,
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection, Transplant International, vol.9, issue.5, pp.506-513, 2010. ,
DOI : 10.1111/j.1432-2277.2009.01017.x
Longitudinal Assessment of Cytomegalovirus (CMV)???Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease, The Journal of Infectious Diseases, vol.195, issue.5, pp.633-644, 2007. ,
DOI : 10.1086/511307
Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients, Transplantation Proceedings, vol.43, issue.4, pp.1159-1161, 2011. ,
DOI : 10.1016/j.transproceed.2011.03.024
Monitoring Cytomegalovirus T-Cell Immunity in Small Bowel/Multivisceral Transplant Recipients, Transplantation Proceedings, vol.42, issue.1, pp.69-73, 2010. ,
DOI : 10.1016/j.transproceed.2009.12.030
Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients, Pediatric Transplantation, vol.29, issue.Suppl 1, pp.18-28, 2012. ,
DOI : 10.1111/j.1399-3046.2011.01531.x
T-Cell Immunity, American Journal of Transplantation, vol.176, issue.8, pp.1749-1754, 2008. ,
DOI : 10.1111/j.1600-6143.2008.02294.x
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia, Transplantation, vol.93, issue.2, pp.195-200, 2012. ,
DOI : 10.1097/TP.0b013e31823c1cd4
Protection from cytomegalovirus after transplantation is correlated with immediate early 1???specific CD8 T cells, The Journal of Experimental Medicine, vol.26, issue.7, pp.1031-1036, 2005. ,
DOI : 10.1146/annurev.iy.13.040195.002553
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213133
Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients, Journal of Infectious Diseases, vol.204, issue.11, pp.1663-1671, 2011. ,
DOI : 10.1093/infdis/jir624
Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients, Clinical Infectious Diseases, vol.56, issue.7, pp.1018-1029, 2013. ,
DOI : 10.1093/cid/cis1035
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.8039-8044, 2000. ,
DOI : 10.1073/pnas.140123497
Polyfunctional Cytomegalovirus-Specific CD4+ and pp65 CD8+ T Cells Protect Against High-Level Replication After Liver Transplantation, American Journal of Transplantation, vol.273, issue.12, pp.2590-2599, 2008. ,
DOI : 10.1111/j.1600-6143.2008.02425.x
Frequencies of Circulating Cytolytic, CD45RA+CD27-, CD8+ T Lymphocytes Depend on Infection with CMV, The Journal of Immunology, vol.170, issue.8, pp.4342-4348, 1950. ,
DOI : 10.4049/jimmunol.170.8.4342
Structural and Functional Analysis of the Costimulatory Receptor Programmed Death-1, Immunity, vol.20, issue.3, pp.337-347, 2004. ,
DOI : 10.1016/S1074-7613(04)00051-2
Dendritic Cell Programming by Cytomegalovirus Stunts Naive T Cell Responses via the PD-L1/PD-1 Pathway, The Journal of Immunology, vol.180, issue.7, pp.4836-4847, 1950. ,
DOI : 10.4049/jimmunol.180.7.4836
CD4 T Cells Allows Stimulation-Independent Assessment of CMV Viremic Episodes in Transplant Recipients, American Journal of Transplantation, vol.205, issue.12, pp.3132-3141, 2013. ,
DOI : 10.1111/ajt.12480
Programmed Death???1 Expression in Liver Transplant Recipients as a Prognostic Indicator of Cytomegalovirus Disease, The Journal of Infectious Diseases, vol.197, issue.1, pp.25-33, 2008. ,
DOI : 10.1086/523652
Advances in Direct T-Cell Alloreactivity: Function, Avidity, Biophysics and Structure, American Journal of Transplantation, vol.91, issue.1, pp.15-26, 2012. ,
DOI : 10.1111/j.1600-6143.2011.03863.x
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments. The Lancet infectious diseases 4, pp.725-738, 2004. ,
DOI : 10.1016/s1473-3099(04)01202-2
Major Expansion of ???? T Lymphocytes following Cytomegalovirus Infection in Kidney Allograft Recipients, The Journal of Infectious Diseases, vol.179, issue.1, pp.1-8, 1999. ,
DOI : 10.1086/314568
Implication of ???? T cells in the human immune response to cytomegalovirus, Journal of Clinical Investigation, vol.103, issue.10, pp.1437-1449, 1999. ,
DOI : 10.1172/JCI5409
Comparison of Cytomegalovirus (CMV) Enzyme-Linked Immunosorbent Spot and CMV Quantiferon Gamma Interferon-Releasing Assays in Assessing Risk of CMV Infection in Kidney Transplant Recipients, Journal of Clinical Microbiology, vol.51, issue.8, pp.2501-2507, 2013. ,
DOI : 10.1128/JCM.00563-13
Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants, Journal of Virological Methods, vol.196, 2013. ,
DOI : 10.1016/j.jviromet.2013.10.036
Detection of Antigen-Specific T Cells Based on Intracellular Cytokine Staining Using Flow-Cytometry, Methods in molecular biology, vol.1064, pp.267-274, 2013. ,
DOI : 10.1007/978-1-62703-601-6_19
Analytical performance of a standardized single-platform MHC tetramer assay for the identification and enumeration of CMV-specific CD8+ T lymphocytes, Cytometry Part A, vol.100, issue.11, pp.992-1000, 2008. ,
DOI : 10.1002/cyto.a.20641
The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients, American Journal of Transplantation, vol.7, issue.Suppl 10, pp.1228-1237, 2010. ,
DOI : 10.1111/j.1600-6143.2010.03074.x
High Incidence of Anticytomegalovirus Drug Resistance Among D+R??? Kidney Transplant Recipients Receiving Preemptive Therapy, American Journal of Transplantation, vol.4, issue.1, pp.202-209, 2012. ,
DOI : 10.1111/j.1600-6143.2011.03766.x
URL : https://hal.archives-ouvertes.fr/hal-00675701
Evaluation of Cytomegalovirus (CMV)???Specific T Cell Immune Reconstitution Revealed That Baseline Antiviral Immunity, Prophylaxis, or Preemptive Therapy but not Antithymocyte Globulin Treatment Contribute to CMV???Specific T Cell Reconstitution in Kidney Transplant Recipients, The Journal of Infectious Diseases, vol.202, issue.4, pp.585-594, 2010. ,
DOI : 10.1086/654931
Cellular Immune Responses to Cytomegalovirus in Renal Transplant Recipients, American Journal of Transplantation, vol.175, issue.1, pp.110-117, 2005. ,
DOI : 10.1182/blood-2002-08-2502
Longitudinal Assessment of Cytomegalovirus (CMV)???Specific Immune Responses in Liver Transplant Recipients at High Risk for Late CMV Disease, The Journal of Infectious Diseases, vol.195, issue.5, pp.633-644, 2007. ,
DOI : 10.1086/511307
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients, Journal of Translational Medicine, vol.6, issue.1, p.29, 2008. ,
DOI : 10.1186/1479-5876-6-29
Primary Cytomegalovirus Phosphoprotein 65-Specific CD8+ T-Cell Responses and T-bet Levels Predict Immune Control During Early Chronic Infection in Lung Transplant Recipients, Journal of Infectious Diseases, vol.204, issue.11, pp.1663-1671, 2011. ,
DOI : 10.1093/infdis/jir624
T-Cell Immunity, American Journal of Transplantation, vol.176, issue.8, pp.1749-1754, 2008. ,
DOI : 10.1111/j.1600-6143.2008.02294.x
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients, American Journal of Transplantation, vol.8, issue.s10, pp.1214-1222, 2009. ,
DOI : 10.1111/j.1600-6143.2009.02618.x
Clinical Utility of Cytomegalovirus Cell-Mediated Immunity in Transplant Recipients With Cytomegalovirus Viremia, Transplantation, vol.93, issue.2, pp.195-200, 2012. ,
DOI : 10.1097/TP.0b013e31823c1cd4
Prospective Analysis of Human Cytomegalovirus DNAemia and Specific CD8+ T Cell Responses in Lung Transplant Recipients, American Journal of Transplantation, vol.36, issue.Suppl 3, pp.2172-2180, 2012. ,
DOI : 10.1111/j.1600-6143.2012.04076.x
Assessment of Cytomegalovirus-Specific Cell-Mediated Immunity for the Prediction of Cytomegalovirus Disease in High-Risk Solid-Organ Transplant Recipients: A Multicenter Cohort Study, Clinical Infectious Diseases, vol.56, issue.6, pp.817-824, 2013. ,
DOI : 10.1093/cid/cis993
Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients, American Journal of Transplantation, vol.55, issue.10, pp.2106-2113, 2007. ,
DOI : 10.1038/sj.icb.7100013
Expanded criteria donors for kidney transplantation, American Journal of Transplantation, vol.1, issue.4, pp.114-125, 2003. ,
DOI : 10.1093/ndt/17.8.1497
RISK FACTORS FOR DELAYED GRAFT FUNCTION IN CADAVERIC KIDNEY TRANSPLANTATION, Transplantation, vol.63, issue.11, pp.1620-1628, 1997. ,
DOI : 10.1097/00007890-199706150-00015
Prediction of Cytomegalovirus (CMV) Plasma Load from Evaluation of CMV Whole-Blood Load in Samples from Renal Transplant Recipients, Journal of Clinical Microbiology, vol.46, issue.2, pp.493-498, 2008. ,
DOI : 10.1128/JCM.01499-07
Recombinant Phenotyping of Cytomegalovirus Sequence Variants Detected After 200 or 100 Days of Valganciclovir Prophylaxis, Transplantation, vol.90, issue.12, pp.1409-1413, 2010. ,
DOI : 10.1097/TP.0b013e3181fdd9d2
Drug-resistant cytomegalovirus in transplant recipients: a French cohort study, Journal of Antimicrobial Chemotherapy, vol.65, issue.12, pp.2628-2640, 2010. ,
DOI : 10.1093/jac/dkq368
URL : https://hal.archives-ouvertes.fr/inserm-00533269
R: A language and environment for statistical computing. R Foundation for Statistical Computing, 2012. ,
Prophylactic Versus Preemptive Oral Valganciclovir for the Management of Cytomegalovirus Infection in Adult Renal Transplant Recipients, American Journal of Transplantation, vol.95, issue.9, pp.2134-2143, 2006. ,
DOI : 10.1111/j.1600-6143.2005.00742.x
Improvement in Long-Term Renal Graft Survival due to CMV Prophylaxis with Oral Ganciclovir: Results of a Randomized Clinical Trial, American Journal of Transplantation, vol.1, issue.2, pp.975-983, 2008. ,
DOI : 10.1097/01.TP.0000142619.01510.A5
Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation, American Journal of Transplantation, vol.324, issue.2, pp.69-77, 2008. ,
DOI : 10.1097/00007890-200011270-00012
Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial, Transplantation, vol.93, issue.1, pp.61-68, 2012. ,
DOI : 10.1097/TP.0b013e318238dab3
Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation, Transplantation Journal, vol.96, issue.4, pp.333-360, 2013. ,
DOI : 10.1097/TP.0b013e31829df29d
Delayed-Onset Primary Cytomegalovirus Disease and the Risk of Allograft Failure and Mortality after Kidney Transplantation, Clinical Infectious Diseases, vol.46, issue.6, pp.840-846, 2008. ,
DOI : 10.1086/528718
Pretransplant Interferon-?? Secretion by CMV-Specific CD8+ T Cells Informs the Risk of CMV Replication After Transplantation, American Journal of Transplantation, vol.49, issue.3, pp.738-745, 2013. ,
DOI : 10.1111/ajt.12049
Optimization of interferon gamma ELISPOT assay to detect human cytomegalovirus specific T-cell responses in solid organ transplants, Journal of Virological Methods, vol.196, pp.157-162, 2014. ,
DOI : 10.1016/j.jviromet.2013.10.036
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection, Transplant International, vol.9, issue.5, pp.506-513, 2010. ,
DOI : 10.1111/j.1432-2277.2009.01017.x
Protection from cytomegalovirus after transplantation is correlated with immediate early 1???specific CD8 T cells, The Journal of Experimental Medicine, vol.26, issue.7, pp.1031-1036, 2005. ,
DOI : 10.1146/annurev.iy.13.040195.002553
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213133
Evaluation and Significance of Cytomegalovirus-Specific Cellular Immune Response in Lung Transplant Recipients, Transplantation Proceedings, vol.43, issue.4, pp.1159-1161, 2011. ,
DOI : 10.1016/j.transproceed.2011.03.024
Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients, Pediatric Transplantation, vol.29, issue.Suppl 1, pp.18-28, 2012. ,
DOI : 10.1111/j.1399-3046.2011.01531.x
Ganciclovir-resistant cytomegalovirus in organ transplant recipients Clinical infectious diseases : an official publication of the Infectious Diseases Society of, America, vol.35, pp.866-872, 2002. ,
Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients, Clinical Infectious Diseases, vol.56, issue.7, pp.1018-1029, 2013. ,
DOI : 10.1093/cid/cis1035
Prediction of cytomegalovirus load and resistance patterns after antiviral chemotherapy, Proceedings of the National Academy of Sciences, vol.97, issue.14, pp.8039-8044, 2000. ,
DOI : 10.1073/pnas.140123497
Emergence of ganciclovir-resistant cytomegalovirus disease among recipients of solid-organ transplants, The Lancet, vol.356, issue.9230, pp.645-649, 2000. ,
DOI : 10.1016/S0140-6736(00)02607-6
Incidence and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infections in 1244 Kidney Transplant Recipients, Transplantation, vol.92, issue.2, pp.217-223, 2011. ,
DOI : 10.1097/TP.0b013e31821fad25
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.350-354, 2006. ,
DOI : 10.1126/science.274.5284.94